Liver cancer screening may not increase survival in chronic hepatitis C
Main Point: Screening for liver cancer may not lead to greater survival among patients infected with chronic hepatitis C virus,
Read MoreStarting from science and ending nowhere…
Main Point: Screening for liver cancer may not lead to greater survival among patients infected with chronic hepatitis C virus,
Read MoreMain Point: Experts comment on HHS 2014-2016 Viral Hepatitis Action Plan. Published in: Annals of Internal Medicine Study Further: Untreated
Read MoreUS Food and Drug Administration (FDA) have recommended two drugs; simeprevir and sofosbuvir, for approval. These drugs will be taken
Read MoreHepatitis C Virus (HCV), the member of Flaviviridae family, has single-stranded RNA, results in infection in almost 170 million people
Read MoreBristol Myers Squibb (BMS) Co. and Johnson & Johnson (J&J) have plans to work together in order to develop medicine
Read More